Archives of Obstetrics and Gynaecology,
Год журнала:
2024,
Номер
5(1), С. 40 - 47
Опубликована: Янв. 1, 2024
Background:
Metrorrhagia
is
defined
as
irregular
uterine
bleeding
occurring
between
normal
menstrual
cycles.
Unlike
menstruation,
metrorrhagia
in
frequency,
duration,
and
volume.
Understanding
the
etiology
of
requires
reviewing
hormonal
regulation
cycle.
Purpose:
This
abstract
provides
an
overview
metrorrhagia,
including
epidemiology,
etiology,
diagnostic
evaluation,
management
approaches,
future
directions.
Main
Body:
has
a
variable
prevalence
depending
on
age
underlying
causes.
Etiologies
include
dysfunction
leading
to
anovulatory
cycles,
structural
abnormalities
like
fibroids
or
polyps,
systemic
conditions
affecting
coagulation
thyroid
function,
iatrogenic
causes
such
intrauterine
devices.
Diagnostic
evaluation
aims
elucidate
cause
through
history,
physical
exam,
laboratory
studies,
imaging
pelvic
ultrasound
endometrial
biopsy.
Treatment
targets
using
therapy
regulate
ovulation
procedural
interventions
for
unresponsive
medical
management.
Traditional
herbal
medicines
provide
another
historical
approach
managing
though
most
lack
standardization.
Looking
forward,
advances
genomics,
biologics,
artificial
intelligence
may
enable
more
personalized,
targeted
therapies.
Conclusion:
arises
from
diverse
etiologies
encompassing
hormonal,
structural,
systemic,
Diagnosis
hinges
thorough
direct
appropriate
treatment
ranging
medications
surgery.
Further
research
individualized
therapies
promises
progress
long-term
Journal of Personalized Medicine,
Год журнала:
2024,
Номер
14(2), С. 135 - 135
Опубликована: Янв. 24, 2024
Infertility
is
a
condition
defined
by
the
failure
to
establish
clinical
pregnancy
after
12
months
of
regular,
unprotected
sexual
intercourse
or
due
an
impairment
person’s
capacity
reproduce
either
as
individual
with
their
partner.
The
authors
have
set
out
succinctly
investigate,
explore,
and
assess
infertility
treatments,
harnessing
potential
stem
cells
effectively
safely
treat
infertility;
in
addition,
this
paper
will
present
legal
regulatory
complexities
at
heart
cell
research,
overview
legislative
state
affairs
six
major
European
countries.
For
couples
who
cannot
benefit
from
assisted
reproductive
technologies
(ART)
infertility,
stem-cells-based
approaches
been
shown
be
highly
promising
approach.
Nonetheless,
lingering
ethical
immunological
uncertainties
require
more
conclusive
findings
data
before
such
treatment
avenues
can
become
mainstream
applied
on
large
scale.
isolation
human
embryonic
(ESCs)
ethically
controversial,
since
collection
involves
destruction
tissue.
Overall,
research
has
resulted
important
new
breakthroughs
infertility.
effort
untangle
complex
web
issues
associated
therapeutic
rely
evidence-based,
broadly
shared
standards,
guidelines,
best
practices
make
sure
that
procreative
rights
patients
reconciled
core
values
medical
ethics.
This
review
article
is
aimed
at
exploring
the
possibility
of
developing
an
integrated
approach
in
management
different
needs
endometrial
cancer
(EC)
patients
seeking
to
become
pregnant.
Life
preservation
woman,
health
baby,
a
precocious
and
–
as
much
possible
minimally
invasive
characterization
fertility
parameters
patient,
together
with
concerns
regarding
obstetric,
neonatal,
adult
risks
children
conceived
via
assisted
reproduction
techniques
(ART)
are
all
essential
aspects
problem
be
taken
into
consideration,
yet
harmonize
such
through
concerted
still
highly
challenging.
aims
illustrate
main
features
EC
how
it
affects
normal
physiology
pre-menopausal
women.
Then,
we
focus
on
prospect
for
miR-based,
molecular
evaluation
patient
status,
including
both
early
diagnosis
staging
and,
similarly,
receptivity
discussing
using
single
specific
panel
circulating
miR
thus
allowing
relatively
fast,
non-invasive
way
perform
testing
significantly
reduced
margin
error.
Finally,
ethical
legal/regulatory
complexities
arising
from
innovative
require
not
only
risk-benefit
analysis;
respect
autonomy
equitable
care
access
allocation
fundamental
issues
well.
Cancers,
Год журнала:
2024,
Номер
16(11), С. 2027 - 2027
Опубликована: Май 27, 2024
Endometrial
cancer
is
one
the
most
prevalent
gynecological
cancers
and,
unfortunately,
has
a
poor
prognosis
due
to
low
response
rates
traditional
treatments.
However,
progress
in
molecular
biology
and
understanding
genetic
mechanisms
involved
tumor
processes
offers
valuable
information
that
led
current
classification
describes
four
subtypes
of
endometrial
cancer.
This
review
focuses
on
pathogenesis
cancers,
such
as
mutations,
defects
DNA
mismatch
repair
pathway,
epigenetic
changes,
or
dysregulation
angiogenic
hormonal
signaling
pathways.
The
preclinical
genomic
investigations
presented
allowed
for
identification
some
molecules
could
be
used
biomarkers
diagnose,
predict,
monitor
progression
Besides
therapies
known
clinical
practice,
targeted
therapy
described
new
treatment
involves
identifying
specific
targets
cells.
By
selectively
inhibiting
these
targets,
key
pathways
can
disrupted
while
normal
cells
are
protected.
connection
between
vital
fight
against
Ongoing
research
trials
exploring
use
standard
agents
combination
with
other
strategies
like
immunotherapy
anti-angiogenesis
improve
outcomes
personalize
patients
approach
potential
transform
management
patients.
In
conclusion,
enhancing
tools
essential
stratifying
risk
guiding
surgery,
adjuvant
therapy,
women
addition,
from
this
may
have
an
value
personalized
patient’s
life.
Vaccines,
Год журнала:
2025,
Номер
13(2), С. 201 - 201
Опубликована: Фев. 17, 2025
Since
the
introduction
of
prophylactic
HPV
vaccines,
both
infection
rates
and
cervical
cancer
have
subsequently
dropped.
Yet,
remains
fourth
most
common
diagnosis
in
women
globally.
As
its
role
development
become
better
understood,
vaccines
emerged
as
a
front
runner
for
improved
therapeutic
treatment.
Recent
studies
shown
that
protein
DNA
may
be
effectively
delivered
via
use
several
different
vectors,
while
combination
therapy
with
immune
checkpoint
inhibitors
provides
even
more
effective
Further
investigation
additional
clinical
into
specific
vaccine
strategies
are
necessary
to
determine
how
treatment
cancer.
This
review
intends
summarize
some
promising
research
on
vaccines.
Such
study
helpful
gynecologists
prevent
manage
patients
infection.
Cancers,
Год журнала:
2025,
Номер
17(6), С. 1035 - 1035
Опубликована: Март 20, 2025
Background:
Endometrial
cancer
incidence
has
been
rising
in
the
United
States.
We
assessed
trends
endometrial
among
both
premenopausal
and
postmenopausal
women
US
from
2001
to
2021.
also
compared
during
2019–2021
assess
impact
of
COVID-19
pandemic.
Methods:
used
data
States
Cancer
Statistics
2001–2021
database
adult
females.
was
corrected
for
hysterectomy
prevalence
age,
adjusted
2000
standard
population.
Results:
From
2021,
rose
86.8
cases
113.8
per
1,000,000
persons
aged
20–49
years
(APC
1.5,
95%
CI
1.2–1.8),
while
70
older,
it
increased
1326.4
1339.4
0.3,
0.1–0.6).
The
recently
decreased
50–69
2016
0.1–0.9;
APC
2021
−1.3,
−2.2–−0.3).
sharply
non-Hispanic
Blacks,
Asians
or
Pacific
Islanders,
South.
2019
2020,
proportion
metastatic
at
diagnosis
across
all
age
groups.
In
returned
levels.
Conclusions:
rates
are
rising,
particularly
women.
During
beginning
pandemic,
decreased,
but
increased.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(12), С. 6387 - 6387
Опубликована: Июнь 9, 2024
Endometrial
cancer
(EC)
is
one
of
the
most
common
malignant
tumors
among
women
in
21st
century,
whose
mortality
rate
increasing
every
year.
Currently,
diagnosis
EC
possible
only
after
a
biopsy.
However,
it
necessary
to
find
new
biomarker
that
will
help
both
and
treatment
non-invasive
way.
Circular
RNAs
(circRNAs)
are
small,
covalently
closed
spherical
stable
long
non-coding
(lncRNAs)
molecules,
which
abundant
body
fluids
human
tissues
expressed
various
ways.
Considering
molecular
classification
EC,
many
studies
have
appeared,
describing
insights
into
functions
mechanisms
circRNAs
EC.
In
this
review
article,
we
focused
on
problem
aspects
its
division,
as
well
biogenesis,
functions,
diagnostic
clinical
significance
Discovery Medicine,
Год журнала:
2024,
Номер
36(182), С. 467 - 467
Опубликована: Янв. 1, 2024
Endometriosis
is
a
medical
condition
affecting
at
least
up
to
10%
of
women
reproductive
age.
This
occurs
when
ectopic
endometrial
glands
and
stroma
implant
outside
the
uterus
there
are
several
theories
regarding
underlying
origins
disease.
one
major
causes
severe
dysmenorrhoea,
chronic
pelvic
pain
infertility.
While
endometriosis
generally
non-malignant
condition,
it
rarely
may
transform
into
an
invasive
cancer,
increase
risk
for
epithelial
ovarian
notably
endometrioid
or
clear
cell
cancer.
Despite
increased
risk,
mechanisms
behind
development
endometriosis-associated
cancer
(EAOC)
not
yet
well
understood.
Recent
investigations
have
delved
intricate
interplay
between
EAOC,
exploring
pathways
involving
oxidative
stress,
inflammation,
hyperestrogenism,
discovery
genetic
mutations
within
endometriotic
lesions
that
hint
transition
towards
carcinoma.
Efforts
been
made
identify
intermediary
which
enable
earlier
detection
malignant
transformation
even
prevention
altogether.
However,
given
rarity
this
malignancy,
still
late
missed
diagnosis,
with
inappropriate
management
being
offered
patient,
higher
poor
prognosis
morbidity
mortality.
scoping
review
aims
summarize
existing
data
on
focus
histologic
subtypes.
It
also
provides
insights
its
identification,
prognosis,
delineating
strategies,
seeking
provide
holistic
understanding
complexities
surrounding
facilitating
further
research
more
effective
treatment
approaches.
Biomedicines,
Год журнала:
2023,
Номер
11(8), С. 2269 - 2269
Опубликована: Авг. 15, 2023
Data
on
genetic
and
immunophenotypical
characteristics
of
uterine
mesonephric-like
adenocarcinoma
(MLA)
remain
limited.
Therefore,
we
aimed
to
investigate
the
clinicopathological,
immunohistochemical,
molecular
features
MLA.
We
performed
targeted
sequencing,
array
comparative
genomic
hybridization,
immunostaining
in
17,
13,
17
MLA
cases,
respectively.
Nine
patients
developed
lung
metastases.
Eleven
experienced
disease
recurrences.
The
most
frequently
mutated
gene
was
Kirsten
rat
sarcoma
viral
oncogene
homolog
(KRAS;
13/17).
Both
primary
matched
metastatic
tumors
harbored
identical
KRAS
(3/4)
phosphatase
tensin
deleted
chromosome
10
(1/4)
mutations,
did
not
harbor
any
additional
mutations.
A
total
2
cases
tumor
protein
53
(TP53)
frameshift
insertion
deletion,
Chromosomal
gains
were
detected
1q
(13/13),
20
(10/13),
(9/13),
12
(6/13).
Programmed
cell
death-ligand
1
overexpression
or
mismatch
repair
deficiency
observed
cases.
Initial
serosal
extension
metastasis
independently
predicted
recurrence-free
survival
with
hazard
ratios
6.30
7.31,
Our
observations
consolidated
clinicopathological
clinicians
pathologists
should
consider
these
make
an
accurate
diagnosis
ensure
appropriate
therapeutic
management
this
rare
entity.
Biomedicines,
Год журнала:
2024,
Номер
12(4), С. 886 - 886
Опубликована: Апрель 17, 2024
Endometrial
cancer
is
the
most
common
gynecologic
malignancy
in
developed
countries,
and
incidence
rising
premenopausal
females.
Type
I
EC
more
than
II
(80%
vs.
20%)
associated
with
a
hyperestrogenic
state.
Estrogen
unopposed
by
progesterone
considered
to
be
main
driving
factor
pathogenesis
of
EC.
Studies
show
that
BMI
>
30
kg/m2,
prolonged
duration
menses,
nulliparity,
presence
polycystic
ovarian
syndrome,
Lynch
syndrome
are
causes
women.
Currently,
there
no
guidelines
established
indicate
patients
who
should
screened.
This
review
aims
synthesize
current
data
on
etiology,
risk
factors,
presentation,
evaluation,
prognosis
endometrial
this
population.
Cancers,
Год журнала:
2024,
Номер
16(18), С. 3155 - 3155
Опубликована: Сен. 14, 2024
Endometrial
cancer
is
becoming
increasingly
common,
highlighting
the
need
for
improved
diagnostic
methods
that
are
both
effective
and
non-invasive.
This
study
investigates
use
of
urinary
fluorescence
spectroscopy
as
a
potential
tool
endometrial
cancer.
Urine
samples
were
collected
from
patients
(n
=
77),
with
benign
uterine
tumors
23),
control
gynecological
attending
regular
checkups
or
follow-ups
96).
These
analyzed
using
synchronous
to
measure
total
fluorescent
metabolome
profile,
specific
ratios
created
differentiate
between
control,
benign,
malignant
samples.
spectral
markers
demonstrated
clinical
applicability
AUC
high
80%.
Partial
Least
Squares
Discriminant
Analysis
(PLS-DA)
was
employed
reduce
data
dimensionality
enhance
class
separation.
Additionally,
machine
learning
models,
including
Random
Forest
(RF),
Logistic
Regression
(LR),
Support
Vector
Machine
(SVM),
Stochastic
Gradient
Descent
(SGD),
utilized
distinguish
controls
patients.
PLS-DA
achieved
an
overall
accuracy
79%
90%.
promising
results
indicate
spectroscopy,
combined
advanced
has
revolutionize
diagnostics,
offering
rapid,
accurate,
non-invasive
alternative
current
methods.